|
S. Fenu, O. Cauli, M. Morelli: Cross-sensitization between the motor activating effects of bromocriptine and caffeine: role of adenosine A2A receptors. Behav. Brain Research, Vol 114, pp 97-105, 2000.
A Pinna, S. Fenu, M. Morelli: Motor stimulant effects of the adenosine A2A receptor antagonist SCH 58261 do not develop tolerance after repeated treatments in 6-hydroxydopamine-lesioned rats. Synapse, Vol: 39, pp 233-238, 2001.
Carta, S. Fenu, M. Morelli: Alterations on GAD67, dynorphin and enkephalin mRNA in striatal output neurons following priming in the 6-OHDA model of parkinson’s disease. Neurological Sciences, Vol 22 (1), pp 59-60, 2001.
S. Fenu, E. Acquas, G. Di Chiara: Role of acetylcholine on dopamine D1 receptor agonist-induced turning behaviour in 6-hydroxydopamine lesioned rats: a microdialysis/behavioural study. Neurological Sciences, Vol 22 (1), pp 63-64, 2001ers on dopamine transmission and Extracellular Signal Regulated Kinase in the rat nucleus accumbens shell and core. J. Neurochem., in press.
S. Fenu, V. Bassareo, G. Di Chiara: A role for dopamine D1 receptors of the nucleus accumbens shell in conditioned taste aversion. Journal of Neuroscience, Vol 21(17), pp 6897-6904, 2001
S. Fenu, G. Di Chiara: Facilitation of conditioned taste aversion learning by systemic amphatamine: role of nucleus accumbens shell dopamine D1 receptors. European J Neuroscience, Vol 18, pp 2025-2039, 2003.
A.R. Carta, S. Fenu, P. Pala, E. Tronci, M. Morelli: Selective modifications in GAD67 mRNA levels in striatonigral and striatopallidal pathways correlate to dopamine agonist priming in 6-hydroxydopamine-lesioned rats. European J Neuroscience, Vol 18, pp 2563-2572, 2003.
N. Simola, S. Fenu, P.G. Baraldi, M.A. Tabrizi, M. Morelli: Blockade of adenosine A2A receptors antagonizes parkinsonian tremor in the rat tacrine model by an action on specific striatal regions. Experimental Neurology; 189(1):182-8, 2004.
G. Di Chiara, V. Bassareo, S. Fenu, M. A. De Luca, L. Spina, C. Cadoni, E. Acquas, E. Carboni, V. Valentini, D. Lecca: Dopamine and drug addiction: the nucleus accumbens shell connection. Neuropharmacology; 47 Suppl 1:227-41, 2004.
S. Fenu, E. Rivas, G. Di Chiara: Differential role of dopamine in drug- and lithium conditioned saccharin avoidance. Physiology & Behaviour 85(1):37-43, 2005.
L. Spina, S. Fenu, R. Longoni, E. Rivas, G. Di Chiara: Nicotine-conditioned single trial place preference: selective role of nucleus accumbens shell dopamine D1 receptors in acquisition. Psychopharmacology 184(3-4): 447-55, 2006.
Pisanu A, E. Acquas, S. Fenu, G. Di Chiara: Modulation of delta9-THC-induced increase of cortical and hippocampal acetylcholine release by µ opioid and D1 dopamine receptors. Neuropharmacology, May; 50(6):661-70, 2006.
S. Fenu, L. Spina, E. Rivas, R. Longoni, G. Di Chiara: Morphine-conditioned single-trial place preference: role of nucleus accumbens shell dopamine receptors in acquisition. Psychopharmacology Aug;187(2):143-53, 2006.
N. Simola, S. Fenu, P.G. Baraldi, M.A. Tabrizi, M. Morelli: Dopamine and adenosine receptor as basis for the treatment of parkinson’s disease. J Neurol Sci, Oct 25;248(1-2):48-52, 2996.
Simola N, Fenu S, Baraldi PG, Tabrizi MA, Morelli M. Involvement of globus pallidus in the antiparkinsonian effects of adenosine A2A receptor antagonists. Exp Neurol, Nov;202(1):255-7, 2006.
|